Medley Management Inc(NYSE:MDLY) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, MDLY scores 1 out of 10 in our fundamental rating. MDLY was compared to 229 industry peers in the Capital Markets industry. MDLY may be in some trouble as it scores bad on both profitability and health. MDLY is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MDLY had negative earnings in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-7.49%
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	-14.15%
PM (TTM)	-8.01%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

There is no outstanding debt for MDLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -3.68, we must say that MDLY is in the distress zone and has some risk of bankruptcy.

A Debt/Equity ratio of -0.97 indicates that MDLY is not too dependend on debt financing.

		Industry Rank	Sector Rank
Debt/Equity	-0.97
Debt/FCF	N/A
Altman-Z	-3.68

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.14 indicates that MDLY may have some problems paying its short term obligations.

MDLY has a Quick Ratio of 0.14. This is a bad value and indicates that MDLY is not financially healthy enough and could expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.14
Quick Ratio	0.14

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MDLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.00%, which is quite impressive.

MDLY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.92%.

The Revenue for MDLY have been decreasing by -13.18% on average. This is quite bad

EPS 1Y (TTM)29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.25%

Revenue 1Y (TTM)-31.92%

Revenue growth 3Y-20.04%

Revenue growth 5Y-13.18%

Sales Q2Q%-20.43%

3.2 Future

MDLY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.61% yearly.

Based on estimates for the next years, MDLY will show a very negative growth in Revenue. The Revenue will decrease by -31.10% on average per year.

EPS Next Y0%

EPS Next 2Y-3.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-11.41%

Revenue Next 2Y-31.1%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MDLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDLY. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	-57.79

4.3 Compensation for Growth

MDLY's earnings are expected to decrease with -3.61% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-3.61%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MDLY has a Yearly Dividend Yield of 11.90%, which is a nice return.

The stock price of MDLY dropped by -29.50% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.

Compared to an average S&P500 Dividend Yield of 2.41, MDLY pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	11.9%

5.2 History

The dividend of MDLY decreases each year by -34.93%.

MDLY has been paying a dividend for over 5 years, so it has already some track record.

Dividend Growth(5Y)-34.93%

Div Incr YearsN/A

Div Non Decr YearsN/A

5.3 Sustainability

The Dividend Rate of MDLY has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.

DP0%

EPS Next 2Y-3.61%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

Medley Management Inc

NYSE:MDLY (7/6/2021, 8:04:00 PM)

5.88

+0.1 (+1.73%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0%

Inst Owner Change0%

Ins Owners403.16%

Ins Owner Change0%

Market Cap3.94M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	11.9%

Yearly Dividend0.7

Dividend Growth(5Y)-34.93%

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.12
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	-57.79

EPS(TTM)-4.26

EYN/A

EPS(NY)-0.17

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS49.63

BVpS-199.51

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.49%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	-14.15%
PM (TTM)	-8.01%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y0%

ROICexcg growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score0

Asset Turnover0.94

Health

		Industry Rank	Sector Rank
Debt/Equity	-0.97
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.14
Quick Ratio	0.14
Altman-Z	-3.68

F-Score0

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.25%

EPS Next Y0%

EPS Next 2Y-3.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-31.92%

Revenue growth 3Y-20.04%

Revenue growth 5Y-13.18%

Sales Q2Q%-20.43%

Revenue Next Year-11.41%

Revenue Next 2Y-31.1%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

Medley Management Inc (MDLY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens